HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Oncology
Sys. Review
Narrative review suggests phytochemicals and phages may augment conventional antibiotics for brucellosis
New plant-based and phage options might help treat stubborn brucellosis infections in people and animals
This narrative review discusses novel strategies for treating brucellosis in humans and animals. The authors note that conventional antibiot…
Standard antibiotics sometimes fail to cure brucellosis, and bacteria are becoming resistant. New methods using plant chemicals and viruses …
Frontiers
May 2, 2026
Pulmonology & Critical Care
Cohort
In vitro amikacin resistance linked to kanamycin cross-resistance but not streptomycin in M. avium-intracellulare complex
Lost to Amikacin? Streptomycin Might Still Work
This single-center retrospective study evaluated cross-resistance among aminoglycosides in 20 patients with amikacin-resistant M.
When amikacin fails to treat stubborn lung infections, streptomycin often remains effective, offering hope for patients facing drug-resistan…
medRxiv
Apr 9, 2026
Infectious Disease
Guidelines outline antimicrobial treatment and prophylaxis recommendations for human plague
Health experts issue updated treatment guidelines for plague infections
A guideline document provides recommended best practices for antimicrobial treatment and prophylaxis of human plague in naturally acquired i…
Updated guidelines now tell doctors how to treat and prevent plague infections from natural outbreaks or bioterrorism attacks.
CDC
Apr 6, 2026